Evidence map›Paper›PMID 30733330›Full record

ArticleDiabetes2019

Comparison of Human and Murine Enteroendocrine Cells by Transcriptomic and Peptidomic Profiling.

Geoffrey P Roberts, Pierre Larraufie, Paul Richards, Richard G Kay, Sam G Galvin, Emily L Miedzybrodzka, Andrew Leiter, H Joyce Li, Leslie L Glass, Marcella K L Ma and 7 more

Registry-linked trialOpen access · greenAbstract readComment
In one paragraph

Article in Diabetes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02836353 (The Metabolic Consequences of Gastrointestinal Surgery), which is not on this map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
17.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02836353 naterminatednot on this map

The Metabolic Consequences of Gastrointestinal Surgery

TypeinterventionalSponsorCambridge University Hospitals NHS Foundation TrustRan2017 to 2019Enrolled81ConditionsGastrectomy, Oesophagectomy, Dumping Syndrome, HypoglycaemiaArmsSomatostatin, Rifaximin
3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 119 citations in OpenAlex.

  1. Trial
  2. Ghrelin Does Not Directly Stimulate Secretion of Glucagon-like Peptide-1.The Journal of clinical endocrinology and metabolism · 2020
    Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Incretin hormones and obesity.The Journal of physiology · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Cellular mechanisms of incretin hormone secretion.Journal of molecular endocrinology · 2024
    Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Geoffrey P RobertsWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, U.K.ORCID http://orcid.org/0000-0001-9554-8404
Pierre LarraufieWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, U.K.
Paul RichardsWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, U.K.
Richard G KayWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, U.K.
Sam G GalvinWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, U.K.
Emily L MiedzybrodzkaWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, U.K.
Andrew LeiterDivision of Gastroenterology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA.
H Joyce LiDivision of Gastroenterology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA.
Leslie L GlassWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, U.K.
Marcella K L MaWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, U.K.
Brian LamWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, U.K.
Giles S H YeoWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, U.K.
Raphaël ScharfmannINSERM U1016, Institut Cochin, Université Paris-Descartes, Paris, France.ORCID http://orcid.org/0000-0001-7619-337X
Davide ChiarugiWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, U.K.
Richard H HardwickCambridge Oesophago-Gastric Centre, Addenbrooke's Hospital, Cambridge, U.K.
Frank ReimannWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, U.K. fmg23@cam.ac.uk fr222@cam.ac.uk.
Fiona M GribbleWellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, U.K. fmg23@cam.ac.uk fr222@cam.ac.uk.ORCID http://orcid.org/0000-0002-4232-2898
Wellcome/MRC Institute of Metabolic Science · GBInserm · FRUniversity of Massachusetts Chan Medical School · USAddenbrooke's Hospital · GB

Funding

Transcriptional events controlling enteroendocrine cell differentiationR01DK110614 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEITER, ANDREW B. · 2016 to 2019
$1.5M
Regulation of enteroendocrine cell differentiation by Neurogenin 3 gene dosageR01DK100223 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEITER, ANDREW B. · 2014 to 2016
$1.0M
Medical Research Council MC_UU_00014/3Medical Research Council MC_UU_00014/5Medical Research Council MC_UU_12012/1Medical Research Council MC_UU_12012/3Medical Research Council MC_UU_12012/5Medical Research Council MR/M009041/1Medical Research Council MR/M024873/1NIDDK NIH HHS R01 DK100223NIDDK NIH HHS R01 DK110614Wellcome Trust 106262
6 · The paper itself

Abstract

Enteroendocrine cells (EECs) produce hormones such as glucagon-like peptide 1 and peptide YY that regulate food absorption, insulin secretion, and appetite. Based on the success of glucagon-like peptide 1-based therapies for type 2 diabetes and obesity, EECs are themselves the focus of drug discovery programs to enhance gut hormone secretion. The aim of this study was to identify the transcriptome and peptidome of human EECs and to provide a cross-species comparison between humans and mice. By RNA sequencing of human EECs purified by flow cytometry after cell fixation and staining, we present a first transcriptomic analysis of human EEC populations and demonstrate a strong correlation with murine counterparts. RNA sequencing was deep enough to enable identification of low-abundance transcripts such as G-protein-coupled receptors and ion channels, revealing expression in human EECs of G-protein-coupled receptors previously found to play roles in postprandial nutrient detection. With liquid chromatography-tandem mass spectrometry, we profiled the gradients of peptide hormones along the human and mouse gut, including their sequences and posttranslational modifications. The transcriptomic and peptidomic profiles of human and mouse EECs and cross-species comparison will be valuable tools for drug discovery programs and for understanding human metabolism and the endocrine impacts of bariatric surgery.

Indexed as

Diabetes Mellitus, Type 2TranscriptomeAnimalsEnteroendocrine CellsGlucagon-Like Peptide 1HumansMiceReceptors, G-Protein-CoupledGlucagon-Like Peptide 1Receptors, G-Protein-Coupled

Identifiers

PMID30733330
PMCPMC6477899
OpenAlexW2953081882

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.